Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

11.04
Delayed Data
As of Jun 23
 +0.02 / +0.18%
Today’s Change
9.38
Today|||52-Week Range
27.02
-38.73%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close11.02
Today’s open11.02
Day’s range10.85 - 11.15
Volume1,268,293
Average volume (3 months)1,725,071
Market cap$688.2M
Dividend yield--
Data as of 06/23/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)-6.51%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book2.73

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-1.11-1.13%
CYTKCytokinetics Inc0.000.00%
VNDAVanda Pharmaceutical...-0.20-1.24%
ENTAEnanta Pharmaceutica...+0.43+1.16%
Data as of 06/23/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$0.10
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts